Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

  • Shareholders' Meeting Information
    (Proxy Documents)

    PROXY 2024 - Genomma Lab Informs The Corporate Bond (Cebures) Program Proposal

    pdf

    PROXY 2024 - Genomma Lab Informs The Dividend Proposal

    pdf

    PROXY 2024 - Genomma Lab Informs The Amount To Be Proposed To The Shareholder’s Meeting For The Cancellation Of Buyback Shares

    pdf

    PROXY 2024 - Genomma Lab informs the amount to be proposed to the Shareholder’s Meeting for the 2024 Share Buyback Program

    pdf

    PROXY 2024 - Genomma Lab informs the amount to be proposed of remuneration for the Board of Directors and The Audit & Corporate Practices Committee Members

    pdf

    PROXY 2024 - Genomma Lab nominees for Board of Directors and Committees to serve from April 2024 to April 2025

    pdf

    PROXY 2023 - Genomma Lab nominees for Board of Directors and Committees to serve from April 2023 to April 2024

    pdf

    PROXY 2023 - Genomma Lab informs the amount to be proposed of remuneration for the Board of Directors and The Audit & Corporate Practices Committee Members

    pdf

    PROXY 2023 - Genomma Lab informs the amount to be proposed to the Shareholder’s Meeting for the 2023 Share Buyback Program

    pdf

    PROXY 2023 - Genomma Lab Informs The Amount To Be Proposed To The Shareholder’s Meeting For The Cancellation Of Buyback Shares

    pdf

    PROXY 2022 - Genomma Lab nominees for Board of Directors and Committees to serve from April 2022 to April 2023

    pdf

    PROXY 2022 - Genomma Lab informs the amount to be proposed of remuneration for the Board of Directors and The Audit & Corporate Practices Committee Members

    pdf

    PROXY 2022 - Genomma Lab informs the amount to be proposed to the Shareholder’s Meeting for the 2022 Share Buyback Program

    pdf

    PROXY 2022 - Genomma Lab informs the proposal to issue a dividend to the shareholders of the Company for an amount of up to 800 million pesos

    pdf

    PROXY 2022 - Genomma Lab informs the proposed amendment to article third of the corporate statutes

    pdf

    PROXY 2021 - Genomma Lab nominees for Board of Directors and Committees to serve from April 2021 to April 2022

    pdf

    PROXY 2021 - Genomma Lab informs the amount to be proposed of remuneration for the Board of Directors and The Audit & Corporate Practices Committee Members

    pdf

    PROXY 2021 - Genomma Lab informs the amount to be proposed to the Shareholder’s Meeting for the 2021 Share Buyback Program

    pdf

    2020 Annual General Meeting Agreements (Spanish Only)

    pdf

    PROXY 2020 - Genomma Lab informs the amount to be proposed of remuneration for the Board of Directors and The Audit & Corporate Practices Committee Members

    pdf

    PROXY 2020 - Genomma Lab nominees for Board of Directors and Committees to serve from April 2020 to April 2021

    pdf

    PROXY 2020 - Genomma Lab informs the amount to be proposed to the Shareholder’s Meeting for the 2020 Share Buyback Program

    pdf

    Proxy 2019 - Terms & Amount for Extension of Revolving Debt Securities Program

    pdf

    Proxy 2019 - Proposed Amount of Remuneration for Board & Committee Members

    pdf

    Proxy 2019 - Proposed Amount for Share Buy Back Program at AGSM 2019

    pdf

    Proxy 2019 - Proposed Special Delegates to Formalize Resolutions at the AGSM 2019

    pdf

Genomma Lab is committed to enriching the well-being of our society by improving life quality of the consumers of our products via the investigation and analysis of the optimal ingredients for the development and commercialization of our personal care and OTC pharmaceutical products, and in so doing, generating the maximum levels of profitability possible for our investors.

Rodrigo Herrera Aspra

Founder and Chairman of the Board

Corporate Governance

Board Of Directors
  • Rodrigo Alonso Herrera Aspra

    Chairman

  • Jorge Brake Valderrama

    Active Vice Chairman of the Board of Directors

  • Ignacio González Rodríguez

    Independent Board Member

  • Marco Francisco Forastieri Muñóz

    Independent Board Member

  • Juan Carlos Gavito Aspe

    Patrimonial Independent Board Member

  • Jorge Ricardo Gutiérrez Muñoz

    Independent Board Member

  • Carlos Javier Vara Alonso

    Independent Board Member

  • Juan Alonso

    Independent Board Member

  • Sabrina Lucila Herrera Aspra

    Propietary Board Member

  • Javier Vale Castilla

    Independent Board Member

  • Simona Visztova

    Independent Board Member

  • Joaquín Ley

    Independent Board Member

Auditing and Corporate Practices Committee
  • Jorge Ricardo Gutiérrez Muñoz

    President

  • Juan Carlos Gavito Aspe

    Independent Board Member

  • Juan Alonso

    Independent Board Member

Executive Managment Team
  • Marco Sparvieri

    Chief Executive Officer

  • Antonio Zamora Galland

    Executive Vice-President and Chief Financial Officer

  • Alejandro Bastón Patiño

    Executive Vice-President of Media and Institutional Affairs

  • Policies and Code of Ethics

    Anti-corruption Policy

    pdf

    Integral Management Policy

    pdf

    Code of Ethics

    pdf
  • Company By-Laws

    pdf

Our brands